UAE Alzheimer’s Disease Drugs Market Analysis

UAE Alzheimer’s Disease Drugs Market Analysis


$ 3999

UAE Alzheimer’s Disease Drugs market was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $158 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Julphar, Lundbeck, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, Roche, Merck & Co., Novartis, Pfizer, and Teva Pharmaceutical among others.

ID: IN10AEPH006 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Nandini Shah

Buy Now

UAE Alzheimer’s Disease Drugs Market Executive Summary

The UAE Alzheimer’s Disease Drugs market was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $158 Mn in 2030. Alzheimer's disease is a brain ailment that gradually damages memory and thinking skills, as well as the capacity to do the most basic tasks. Alzheimer's patients can endure behavioural and personality changes. Alzheimer's disease is not a natural component of the ageing process. It is caused by complex brain alterations that begin years before symptoms manifest and contribute to the loss of brain cells and their connections.

According to a new study published in the Lancet Public Health, the UAE and other Gulf nations will see the greatest rise in the number of people living with dementia over the next 30 years. The UAE is expected to witness a 1,795% increase in dementia cases by 2050, while neighbouring Gulf countries such as Qatar and Bahrain will also see a 1,926% and 1,084% increase in dementia cases, respectively.

uae alzheimers disease drugs market analysis

Market Dynamics

Market Growth Drivers

As the population in UAE continues to age, the prevalence of Alzheimer's disease is expected to increase. In the UAE in 2020, only 1.6 people over the age of 65 were dependent on 100 working-age people. However, by 2050, this figure will have risen to 18.5, posing financial, social, and medical challenges for families and the UAE government. This will drive the demand for drugs that can treat the symptoms of the disease. There is growing awareness about Alzheimer's disease in UAE, which has led to an increased demand for treatment options. Patients and their families are seeking effective drugs that can improve the quality of life for those suffering from the disease. The development of new drugs and therapies for Alzheimer's disease is ongoing. This has led to the introduction of new drugs in the market, which has further driven the growth of the market. The UAE government is taking steps to improve healthcare infrastructure in the country, including investing in the development of new drugs for the treatment of Alzheimer's disease. This is expected to further drive the growth of the market. The UAE is a high-income country with relatively high healthcare expenditures. The increase in healthcare spending is expected to lead to greater investment in the development and distribution of drugs for the treatment of Alzheimer's disease.

Market Restraints

Alzheimer's medications can be costly, keeping them out of reach for many people. The high cost of medications is frequently highlighted as a barrier to treatment availability. Early detection and intervention are critical for good Alzheimer's disease care. Unfortunately, there is a lack of understanding about the condition and its symptoms, which can cause diagnosis and treatment to be delayed. Certain pharmaceuticals that are available in other parts of the world may not be available in the UAE, limiting patients' treatment options. Companies seeking to bring innovative pharmaceuticals to market in the UAE may face difficulties due to the regulatory environment. The approval procedure can be time-consuming, and regulatory requirements might be burdensome Alzheimer's disease is still stigmatised in some regions of the UAE, making it difficult for sufferers and their families to seek and get treatment.

Competitive Landscape

Key Players

  • Eisai Co.
  • Eli Lilly and Company
  • Johnson and Johnson
  • Roche
  • Novartis
  • Pfizer
  • Julphar
  • Lundbeck
  • Shalina Healthcare

Recent Updates

After the United States, the UAE has become the world's second country to authorise the registration and usage of Biogen's Aduhelm (aducanumab), the first and only medicine to treat the early stages of Alzheimer's disease. Aduhelm had already been licenced by the Food and Drug Administration (FDA) in the United States, and its clearance by UAE authorities came in accordance with the Ministry of Health and Prevention's Fast Track/Accelerate Process method (MoHAP).

Healthcare Policies and Regulatory Landscape

The healthcare policy in the UAE aims to provide accessible and affordable healthcare services to all its citizens and residents. The government is actively investing in the healthcare sector to improve the infrastructure, facilities, and services provided to patients in the country.

In terms of the Alzheimer's drugs market, the UAE Ministry of Health and Prevention (MOHAP) has taken steps to regulate the import, sale, and use of drugs for the treatment of Alzheimer's disease. The MOHAP has established guidelines for the registration and approval of new drugs, which must meet certain safety and efficacy standards before they can be approved for use in the UAE. In addition, the UAE government has established partnerships with global healthcare organizations and pharmaceutical companies to improve access to new and innovative drugs for the treatment of Alzheimer's disease. For example, the MOHAP has signed a memorandum of understanding with the Global Alzheimer's Platform Foundation (GAP) to support the development of clinical trials for Alzheimer's disease in the UAE.

Reimbursement Scenario

In the UAE, healthcare is provided by a mix of public and private healthcare providers. The government provides healthcare services to citizens and residents through a publicly-funded system known as the Dubai Health Authority (DHA). The DHA provides coverage for a range of healthcare services, including prescription drugs. For patients with health insurance, the coverage for prescription drugs depends on the specific policy and provider. Some insurance policies may cover the cost of Alzheimer's drugs, while others may not. The government has taken steps to address this issue by introducing price controls for certain drugs and by providing financial assistance to low-income patients. In addition, some pharmaceutical companies may offer patient assistance programs to help eligible patients access their drugs.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Alzheimer's Disease Drugs Market Segmentation

By Drug Class (Revenue, USD Bn)

  • Cholinesterase Inhibitors (Donepezil, Rivastigmine, Galantamine)
  • N-Methyl-D-Aspartate (NMDA) Receptor Antagonists (Memantine)
  • Combination Drugs
  • Others (Lecanemab, Aducanumab)

Drug segmentation is the process of dividing a set of drugs into different categories or classes based on their pharmacological properties, therapeutic uses, and other characteristics. Here, Alzheimer’s Disease Drugs Market is segmented into Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Combination Drugs, and others like (Lecanemab, Aducanumab).

By Distribution Channel (Revenue, USD Bn)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Route of Administration

  • Oral
  • Transdermal
  • Intravenous

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 March 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up